St. John's wort as "alternative" treatment for "the blues" is drug claim, FDA states.
This article was originally published in The Tan Sheet
Executive Summary
ST. JOHN's WORT AS "ALTERNATIVE" TREATMENT FOR "THE BLUES" IS DRUG CLAIM, FDA tells Shaklee in a recently released "courtesy" letter. The San Francisco-based company filed structure/function claims with FDA for its MoodLift product with St. John's wort including "A safe, natural alternative for millions who suffer from the blues" Jan. 30. "The claim implies that this product is intended to treat a disease, namely depression, and that the product is intended for use as an alternative to approved drugs for the treatment of this disease," FDA states.